Screen of existing drugs finds compounds active against MERS coronavirus
2 institutional releases
Published in Antimicrobial Agents and Chemotherapy · View the paper (DOI)
Researchers at NIH screened 290 approved compounds and identified 27 with activity against both MERS-CoV and SARS coronavirus. These compounds, from various pharmaceutical classes, inhibited the viruses' ability to enter and infect cells. The study provides a potential solution for outbreaks due to emerging viruses.
Coverage from 2 institutions
- Screen of existing drugs finds compounds active against MERS coronavirus NIH/National Institute of Allergy and Infectious Diseases · May 20, 2014 · first to report
- University of Maryland School of Medicine research finds drugs that may treat MERS virus University of Maryland School of Medicine · May 21, 2014